PFIZER

The earnings calendar is a busy one while data on durable goods orders, and indexes on housing and consumer sentiment, are also awaited.

Water vapor exuded by e-cigarette users will expose a bystander to nicotine, but not carbon monoxide and other harmful compounds, a study finds.

Investors prepare for yet another earnings-heavy day with Wednesday’s FOMC meeting playing on their minds.

A board advised against using Xalkori, a lung cancer treatment, in the British National Health Service.

Lawsuits buy big pharma more time in India, but it's the drug development divisions that will ultimately lose out.

India revoked a patent on the breast cancer drug Tykerb, claiming it wasn't innovative enough to warrant protections.

However, the largest U.S. drugmaker's adjusted income fell 10% to $4 billion, or 56 cents per share.

The pharma giant aims to combat generic-drugmaker competition by restructuring and focusing on drugs for humans.

The move puts Amgen in the lead to buy the cancer-drug maker.

Onyx, a California-based cancer drug company, could soon be batting away buyout offers, as pharma majors prepare for a bidding war.

Israel generic drug producer Teva will pay Pfizer $1.6 billion in a new patent dispute settlement announced Wednesday.

The insider trading trial of Mathew Martoma, a former hedge fund portfolio manager for SAC Capital Advisors, is set for November.

Illinois' Hospira, which produces generic drugs, is being investigated by the FDA for violations at its Indian facility.

These are the top five American companies with the most accumulated offshore profits. And no, Apple isn't one of them.

In a first for the drug industry, Pfizer Inc. will begin selling its popular erectile dysfunction pill Viagra directly to patients on its website.

Drugmaker Merck will discuss new drugs and Q1 sales trends as it braces for new generic competition.

The recent Indian Supreme Court verdict against Swiss pharma major Novartis seems to have underscored the need for tailor–made business models in emerging economies.

Hope Chanda says that taking Xanax makes her a "better mom."

Patent expirations for lucrative blockbuster drugs eroded fourth-quarter sales for top drugmakers.

Investigators are looking into the disappearance of $700,000 in gold dust from a medical research lab. At this time it is unknown if the gold dust was stolen or misplaced.

The pharmaceutical industry is grappling with diminishing R&D productivity -- exemplified by a drop in revenue per new drug approval.